Top

International Journal of Clinical Oncology

Published in:

01-06-2017 | Original Article

Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations

Authors: Tatsunori Miyata, Yo-ichi Yamashita, Takanobu Yamao, Naoki Umezaki, Masayo Tsukamoto, Yuki Kitano, Kensuke Yamamura, Kota Arima, Takayoshi Kaida, Shigeki Nakagawa, Katsunori Imai, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Hideo Baba

Published in: International Journal of Clinical Oncology | Issue 3/2017

Abstract

Background

The postoperative complication is one of an indicator of poor prognosis in patients with several gastroenterological cancers after curative operations. We, herein, examined prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.

Methods

We retrospectively analyzed 60 patients with intrahepatic cholangiocarcinoma who underwent primary curative operations from June 2002 to February 2016. Prognostic impacts of postoperative complications were analyzed using log-rank test and Cox proportional hazard model.

Results

Postoperative complications (Clavien-Dindo classification grade 3 or more) occurred in 13 patients (21.7%). Overall survival of patients without postoperative complications was significantly better than that of patients with postoperative complications (p = 0.025). Postoperative complications are independent prognostic factor of overall survival (hazard ratio 3.02; p = 0.030). In addition, bile duct resection and reconstruction (Odds ratio 59.1; p = 0.002) and hepatitis C virus antibody positive (Odds ratio 7.14; p= 0.022), and lymph node dissection (Odds ratio 6.28; p = 0.040) were independent predictors of postoperative complications.

Conclusion

Postoperative complications may be an independent predictor of poorer survival in patients with intrahepatic cholangiocarcinoma after curative operations. Lymph node dissection and bile duct resection and reconstruction were risk factors for postoperative complications, therefore we should pay attentions to perform lymph node dissections, bile duct resection and reconstruction in patients with intrahepatic cholangiocarcinoma.

Khan SA, Taylor-Robinson SD, Toledano MB et al (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806–813CrossRefPubMed

Ikai I, Arii S, Okazaki M et al (2007) Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 37:676–691CrossRefPubMed

Shaib YH, Davila JA, McGlynn K et al (2004) Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 40:472–477CrossRefPubMed

Taylor-Robinson SD, Toledano MB, Arora S et al (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 48:816–820CrossRefPubMedPubMedCentral

de Jong MC, Nathan H, Sotiropoulos GC et al (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29:3140–3145CrossRefPubMed

Shimada M, Yamashita Y, Aishima S et al (2001) Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg 88:1463–1466CrossRefPubMed

Matsuda A, Matsumoto S, Seya T et al (2013) Does postoperative complication have a negative impact on long-term outcomes following hepatic resection for colorectal liver metastasis?: a meta-analysis. Ann Surg Oncol 20:2485–2492CrossRefPubMed

Merkow RP, Bilimoria KY, Tomlinson JS et al (2014) Postoperative complications reduce adjuvant chemotherapy use in resectable pancreatic cancer. Ann Surg 260:372–377CrossRefPubMed

Baba Y, Yoshida N, Shigaki H et al (2016) Prognostic impact of postoperative complications in 502 patients with surgically resected esophageal squamous cell carcinoma: a retrospective single-institution study. Ann Surg 264:305–311CrossRefPubMed

10.

Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545CrossRefPubMed

11.

Doussot A, Lim C, Gomez Gavara C et al (2016) Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma. Br J Surg 103:1887–1894CrossRefPubMed

12.

Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral

13.

Adachi T, Eguchi S, Beppu T et al (2015) Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: a multi-institutional study by the Kyushu study group of liver surgery. Ann Surg Oncol 22:2269–2278CrossRefPubMed

14.

Hyder O, Marques H, Pulitano C et al (2014) A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg 149:432–438CrossRefPubMed

15.

Spolverato G, Yakoob MY, Kim Y et al (2015) Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer 121:2730–2739CrossRefPubMed

16.

Sharma P, Zargar H, Spiess PE (2016) Surgical advances in inguinal lymph node dissection: optimizing treatment outcomes. Urol Clin North Am 43:457–468CrossRefPubMed

17.

Kilgore LC, Partridge EE, Alvarez RD et al (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56:29–33CrossRefPubMed

18.

Frost JA, Webster KE, Bryant A et al (2015) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev (9):CD007585. doi:10.1002/14651858.CD007585.pub3

19.

Kang J, Hur H, Min BS et al (2011) Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol 18:704–710CrossRefPubMed

20.

Baba Y, Watanabe M, Shigaki H et al (2013) Negative lymph-node count is associated with survival in patients with resected esophageal squamous cell carcinoma. Surgery 153:234–241CrossRefPubMed

21.

Tsai HL, Huang CW, Yeh YS et al (2016) Factors affecting number of lymph nodes harvested and the impact of examining a minimum of 12 lymph nodes in stage I–III colorectal cancer patients: a retrospective single institution cohort study of 1167 consecutive patients. BMC Surg 16:17CrossRefPubMedPubMedCentral

22.

Yamashita Y, Taketomi A, Morita K et al (2008) The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res 28:2353–2359PubMed

23.

Weber SM, Ribero D, O’Reilly EM et al (2015) Intrahepatic cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17:669–680CrossRef

24.

Aishima S, Kuroda Y, Nishihara Y et al (2007) Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol 31:1059–1067CrossRefPubMed

25.

Chok KS, Ng KK, Poon RT et al (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87CrossRefPubMed

26.

Kusano T, Sasaki A, Kai S et al (2009) Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection. Eur J Surg Oncol 35:1179–1185CrossRefPubMed

27.

Ruan DY, Lin ZX, Li Y et al (2015) Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World J Gastroenterol 21:5598–5606CrossRefPubMedPubMedCentral

28.

Wong VK, Malik HZ, Hamady ZZ et al (2007) C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer 96:222–225CrossRefPubMedPubMedCentral

29.

Lundy J, Ford CM (1983) Surgery, trauma and immune suppression. Evolving the mechanism. Ann Surg 197:434–438CrossRefPubMedPubMedCentral

30.

Wortel CH, van Deventer SJ, Aarden LA et al (1993) Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery 114:564–570PubMed

Title: Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations
Authors: Tatsunori Miyata
Yo-ichi Yamashita
Takanobu Yamao
Naoki Umezaki
Masayo Tsukamoto
Yuki Kitano
Kensuke Yamamura
Kota Arima
Takayoshi Kaida
Shigeki Nakagawa
Katsunori Imai
Daisuke Hashimoto
Akira Chikamoto
Takatoshi Ishiko
Hideo Baba
Publication date: 01-06-2017
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 3/2017
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-017-1099-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2017

Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy

Multivariate evaluation of Thyroid Imaging Reporting and Data System (TI-RADS) in diagnosis malignant thyroid nodule: application to PCA and PLS-DA analysis

Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer

Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions

Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy

Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population

Keynote webinar | Spotlight on antibody–drug conjugates in cancer